Platelets treated with pathogen reduction technology: current status and future direction

Allogeneic platelets collected for transfusion treated with pathogen reduction technology (PRT), which has been available in some countries for more than a decade, are now increasingly available in the United States (US). The implementation of PRT-treated platelets, also known as pathogen-reduced pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Wen, Fung, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6979468/
https://www.ncbi.nlm.nih.gov/pubmed/32047608
http://dx.doi.org/10.12688/f1000research.20816.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6979468/
https://www.ncbi.nlm.nih.gov/pubmed/32047608
http://dx.doi.org/10.12688/f1000research.20816.1

Ejemplares similares